Toronto, ON - Among congestive heart failure (CHF) patients completing a full course of enhanced external counterpulsation (EECP) therapy, the unconventional treatment is associated with significant ...

Dr Andrew D Michaels (University of California, San Francisco) and colleagues publish the first experience with repeat EECP in the February 1, 2005 issue of the American Journal of Cardiology, noting, ...

WESTBURY, N.Y.--(BUSINESS WIRE)--March 10, 2006--Vasomedical, Inc. (Nasdaq SC: VASO), a leader in the noninvasive treatment and management of cardiovascular diseases, reconfirmed that the majority of ...

WESTBURY, N.Y.--(BUSINESS WIRE)-- Vasomedical, Inc. (“Vasomedical”) (VASO.PK), a global provider of medical devices, today announced the execution of a definitive agreement with Edgary Consultants LLC ...

Over the last year, Fred Lembkie, 62, has had three heart attacks, a failed bypass surgery, two subsequent angioplasty procedures and stents inserted into his arteries. When the Portland, Ore., man ...

Flow Therapy, the nation's leading provider of Enhanced External Counter-pulsation (EECP®) services, a non-invasive treatment that increases blood flow to the heart and throughout the cardiovascular ...

In a small study of long COVID-19 patients, those with and without coronary artery disease demonstrated improvement of a variety of symptoms, including fatigue, breathing difficulties and chest ...

In a small study of long COVID-19 patients, those with and without coronary artery disease demonstrated improvement of a variety of symptoms, including fatigue, breathing difficulties and chest ...

Company Invites Congressmen to Local EECP Therapy Centers to Educate Them about How Non-Invasive Treatment Can Save the Healthcare System Millions Vasomedical, Inc. ("Vasomedical") (OTC BB: VASO), a ...

Vasomedical, Inc. (NASDAQSmallCap: VASO), announced today that five major third-party payers in the United Kingdom have expanded their reimbursement structures to include EECP external ...